Cargando…
Loss of E-Cadherin Expression and Outcome among Patients with Resectable Pancreatic Adenocarcinomas
Only a minority of patients who undergo surgical resection for pancreatic ductal adenocarcinoma are cured. Since patient outcome is not reliably predicted using pathological factors (tumor stage, differentiation, resection margin status) alone, markers of tumor behavior are needed. One candidate pre...
Autores principales: | Hong, Seung-Mo, Li, Ang, Olino, Kelly, Wolfgang, Christopher L., Herman, Joseph M., Schulick, Richard D., Iacobuzio-Donahue, Christine, Hruban, Ralph H., Goggins, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155013/ https://www.ncbi.nlm.nih.gov/pubmed/21552209 http://dx.doi.org/10.1038/modpathol.2011.74 |
Ejemplares similares
-
Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma
por: Dal Molin, Marco, et al.
Publicado: (2016) -
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
por: Handra-Luca, A, et al.
Publicado: (2011) -
Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma
por: Rodić, Nemanja, et al.
Publicado: (2015) -
Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment
por: Sebastian, Aimy, et al.
Publicado: (2023) -
An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course
por: Kohutek, Zachary A., et al.
Publicado: (2017)